Literature DB >> 35835922

Atypical course of a caesarean scar pregnancy.

Katharina Schlammerl1, Stefan Kommoss1, Bernhard Krämer1, Markus Hoopmann1, Cornelia Bachmann2.   

Abstract

Entities:  

Year:  2022        PMID： 35835922     DOI： 10.1007/s00404-022-06697-9

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN： 0932-0067            Impact factor:   2.493


× No keyword cloud information.
  6 in total

1.  Cesarean scar ectopic pregnancies - a retrospective case series at an Australian tertiary referral center.

Authors:  Justine Toh; Andrea Deussen; Nooraishah Yasin; Monika Skubisz; Jodie Dodd
Journal:  Int J Gynaecol Obstet       Date:  2022-03-19       Impact factor: 3.561

2.  Methotrexate/mifepristone-combined with embryo removal in the treatment of caesarean scar pregnancy.

Authors:  S-S Yu; M-Y Ma; R Zhou; R Liang; Z Duan; J Wang; Y Tian; J Jiang; X He; Q Zhou
Journal:  Eur Rev Med Pharmacol Sci       Date:  2022-03       Impact factor: 3.507

3.  Laparoscopic approach for a cesarean scar pregnancy.

Authors:  Stavros Karampelas; Sara Engels; Christian Birbarah; Michelle Nisolle
Journal:  Fertil Steril       Date:  2022-03-28       Impact factor: 7.329

4.  Surgical outcomes of cesarean scar pregnancy: an 8-year experience at a single institution.

Authors:  Xiaofeng Xu; Dongdong Li; Lan Yang; Xiujuan Jing; Xiangyi Kong; Dezhu Chen; Tong Ru; Huaijun Zhou
Journal:  Arch Gynecol Obstet       Date:  2021-01-03       Impact factor: 2.344

Review 5.  Methotrexate versus expectant management in ectopic pregnancy: a meta-analysis.

Authors:  Ahmed Kunwer Naveed; Muhammad Umair Anjum; Ali Hassan; Sumbal Nasir Mahmood
Journal:  Arch Gynecol Obstet       Date:  2021-09-15       Impact factor: 2.344

6.  Letter to the editor related to the article "Surgical outcomes of cesarean scar pregnancy: an 8‑year experience at a single institution" published by Xu et al.

Authors:  Cem Yener; Cenk Sayın; Cihan Inan; Esra Altan; Sinan Ateş; Füsun Varol
Journal:  Arch Gynecol Obstet       Date:  2021-06-26       Impact factor: 2.344
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.